Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
Titel:
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
Auteur:
Coluccia, Addolorata Maria Luce Cirulli, Teresa Neri, Paola Mangieri, Domenica Colanardi, Maria Cristina Gnoni, Antonio Di Renzo, Nicola Dammacco, Franco Tassone, Pierfrancesco Ribatti, Domenico Gambacorti-Passerini, Carlo Vacca, Angelo